BCAL files Form 144 to sell 17,000 shares
BCAL submitted a Form 144 notice to sell 17,000 shares of Common Stock for an aggregate amount of $322,931.30.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BCAL submitted a Form 144 notice to sell 17,000 shares of Common Stock for an aggregate amount of $322,931.30.
The filing lists 32,164,824 shares outstanding (date shown 05/11/2026) and records several issuer grants: 7,350 shares dated 12/01/2021, 7,350 dated 12/01/2022, 2,243 dated 03/03/2023, and 57 dated 05/05/2023. The notice identifies sales through NASDAQ and lists Computershare as the transfer agent.
Insights
Form 144 filed for proposed resale of 17,000 common shares totaling $322,931.30.
The filing is a regulatory notice that an affiliate intends to sell 17,000 shares of Common Stock on NASDAQ, with $322,931.30 shown as the aggregate amount. It lists multiple prior issuer grants by date and per‑grant share counts.
Timing and exact sale mechanics are not specified beyond the listing of NASDAQ and the transfer agent; subsequent Form 4 or transaction reports would show executed sales and cash‑flow recipients if and when sales occur.
Key Figures
Key Terms
Form 144 regulatory
Issuer grant financial
Transfer agent other
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.